Sildenafil provides sustained neuroprotection in the absence of learning recovery following the 4-vessel occlusion/internal carotid artery model of chronic cerebral hypoperfusion in middle-aged rats  by Dias Fiuza Ferreira, Emilene et al.
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a  b  s  t  r  a  c  t
In this  study,  we  tested  whether  the phosphodiesterase-5  inhibitor  sildenaﬁl  protects  against  neu-
rodegeneration  and  facilitates  recovery  from  learning  deﬁcits  examined  long  after  chronic  cerebral
hypoperfusion  (CCH)  induced  by  the 4-vessel  occlusion/internal  carotid  artery  (4-VO/ICA)  model  in
middle-aged  rats.  Male  Wistar  rats  (12–15  months  of age)  were  subjected  to permanent  3-stage  4-VO/ICA
with  an  interstage  interval  of  4 days.  Sildenaﬁl  (3 mg/kg,  p.o.)  was  administered  at one  dose  per  day  for  10
days,  beginning  soon  after  the  ﬁrst  occlusion  stage.  Three  months  later,  learning  in a non-food-rewarded,
eight-arm  radial  maze  task  was  tested.  Learning  performance  is  expressed  as  the  latency  to  ﬁnd  a  goal
box  and  the  number  of reference  or working  memory  errors.  Histological  examination  was  performed
1–3  days  after  behavioral  testing.  In the vehicle-treated  group,  permanent  4-VO/ICA  markedly  disrupted
learning  performance  and  caused  moderate-to-severe  neurodegeneration  in  the  CA1-CA4  subﬁelds  ofeuroprotection
earning deﬁcit
the  hippocampus  (56.2%),  dentate  gyrus  (DG;  19.2%),  retrosplenial  cortex  (RS cortex;  47.4%), and  parietal
association  cortex  (PtA  cortex;  38.2%).  Sildenaﬁl  treatment  did  not  prevent  4-VO/ICA-induced  learn-
ing  deﬁcits,  whereas  neurodegeneration  was  signiﬁcantly  reduced  in the  CA1-CA4  subﬁelds  (30.5%),  DG
(7.2%),  RS  cortex  (11.8%),  and  PtA  cortex  (6.5%).  Advancing  previous  ﬁndings  from  our laboratory,  this
study  suggests  that while  sildenaﬁl  can  provide  important  neuroprotection  in  different  brain  regions  of
middle-aged  rats subjected  to CCH,  such  histological  effect  does  not  translate  into  cognitive  recovery.. Introduction
Ample experimental and clinical observations support the
ypothesis that a state of chronic cerebral hypoperfusion (CCH)
epresents an etiologic factor of age-related neurodegenerative dis-
ases and dementia (de la Torre et al., 2002). Prevention against
CH-related risk factors, mainly hypertension and chronic heart
isease, constitutes the primary recommendation to reduce the
revalence of neurodegenerative disease associated with CCH
de la Torre, 2009). However, once CCH occurs and evolves, the
uestion arises whether the progression of brain damage and
ognitive impairment can be mitigated pharmacologically. Drugs
uch as sildenaﬁl (Viagra) possess pharmacological properties by
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which their therapeutic indication transcends the area of erectile
dysfunction and pulmonary hypertension to include the treat-
ment of vascular-related CNS disorders among other conditions
(Vlachopoulos et al., 2009). Sildenaﬁl acts primarily by selectively
inhibiting phosphodiesterase type-5 (PDE5) and increasing intra-
cellular cyclic guanosine monophosphate (cGMP) that in turn leads
to vascular smooth muscle relaxation, vasodilation, and perhaps
overall cerebral circulation improvement (Ghofrani et al., 2006).
Beyond its direct action on vascular smooth muscles, sildenaﬁl
exerts important preconditioning and antiapoptotic actions in the
myocardium, followed by reduced heart infarct size and improved
myocardial function after experimental ischemia (Das et al., 2005;
Kukreja et al., 2005). As deﬁned elsewhere, “pharmacological pre-
conditioning refers to the action of compounds that trigger the
preconditioning signaling cascades without a physical stimulus”
(Dimagl et al., 2009). Whether sildenaﬁl can induce precondition-
ing in the brain is unknown. However, sildenaﬁl modulates the
Open access under the Elsevier OA license.nitric oxide (NO)/cGMP pathway, the signaling of which promotes
angiogenesis, neurogenesis, axonal outgrowth, and synaptic plas-
ticity during development and in the adult animal (Prickaerts et al.,
2002; Zhang et al., 2005). In a rat model of stroke, sildenaﬁl induced
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Fig. 1. Schematic representation of the experimental protocol that delineates the
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chases of the 3-stage 4-VO/ICA model with an ISI of 4 days, periods of sildena-
l  administration, habituation to the test environment, acquisition training, and
istology. VA, vertebral artery; ICA, internal carotid artery; ISI, interstage interval.
ngiogenesis, neurogenesis, and axonal remodeling, improved
erebral blood ﬂow in the periinfarct area, and facilitated func-
ional recovery (Zhang et al., 2006; Li et al., 2007; Ding et al., 2011).
cutely, sildenaﬁl improves learning and memory function in sev-
ral rodent species tested in different behavioral tasks (Reneerkens
t al., 2009).
However, whether sildenaﬁl is effective against the neuro-
istological and behavioral outcomes of CCH has not yet been
ystematically investigated (Romanini et al., 2010). In that study,
oung rats were subjected to a 4-vessel occlusion/internal carotid
rtery (4-VO/ICA) model of CCH, which is based on the perma-
ent, stepwise occlusion of the vertebral arteries (VAs) and internal
arotid arteries (ICAs; Neto et al., 2005; Barros et al., 2009). Sildena-
l was found to reduce both the rate of mortality and hippocampal
eurodegeneration, but its effect on behavior was  not evaluated.
nexpectedly, permanent 4-VO/ICA did not impact the ability of
oung rats to perform the radial maze task. When imposed to
iddle-aged rats, however, permanent 4-VO/ICA caused not only
ippocampal and cortical neurodegeneration, but also learning and
emory deﬁcits (Ferreira et al., 2011). Therefore, and given conti-
uity to our previous investigation, in the present study we sought
o examine whether the treatment with sildenaﬁl could provide
oth neurohistological protection and behavioral recovery after
ermanent 4-VO/ICA in middle-aged rats.
. Materials and methods
.1. Subjects
Seventy-one middle-aged (12–15-month-old, 490–600 g body weight) male
istar rats (inbred strain) were assigned to the following three groups: sham oper-
tion (n = 13), 4-VO/ICA + vehicle (n = 34), and 4-VO/ICA + sildenaﬁl (n = 24). The rats
ere housed at a controlled temperature (22 ± 1 ◦C) on a 12 h/12 h light/dark cycle
lights on at 7:00 AM). Food and water were provided ad libitum throughout the
xperiment. The materials and methods were approved by our Ethics Committee
n Animal Experimentation (protocol no. 044/2008).
.2. Surgery
Fig. 1 provides a schematic of the entire experimental protocol. The animals were
nesthetized with ketamine (15 mg/kg) plus xylazine (1.0 mg/kg) administered
ntramuscularly. Permanent 4-VO/ICA or sham surgery was performed gradually
n  three stages according to the sequence VA → ICA → ICA, with an interstage inter-
al (ISI, →) of 4 days. For bilateral occlusion of the VAs, the tip of a unipolar electrode
as  inserted into the alar foramen of the ﬁrst cervical vertebra and gently rotated
ntil the presence of hemorrhage ensured vessel rupture. The hemorrhage was then
mmediately staunched by a 3–4 mA  electrical current. This procedure ensures com-
lete  and irreversible VA occlusion. The ICAs were carefully dissected from adjacent
issues and permanently ligated using cotton thread. After each occlusion stage, the
ncision was  sutured, and the animal was  returned to its home cage until the next
urgery. Rectal temperature was monitored with a digital thermometer (Minipa,
PPA MT-520, São Paulo, Brazil) using a rectal probe inserted to a depth of approxi-
ately 6 cm.  Core temperature was controlled only during surgery and maintained
t  approximately 37.5 ◦C by a heating blanket. The animals assigned to the sham
urgery group were subjected to the same surgical procedures as their counterparts
ut did not receive vessel occlusions.
.3. Drug preparation and treatmentSildenaﬁl citrate (1-[4-etoxido-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-
H-pirazolo[4,3-d]pyrimidine-5-yl)phenylsulfonyl]-4-methylpiperazine citrate;
amma  Pharmaceuticals, Beijing, China) was dissolved in sterile 0.9% saline
vehicle) and administered by gavage at 3.0 mg/kg in a volume of 1.0 ml/kg. We
hoose this dose because it effectively affords neuroprotection in young ratssearch Bulletin 90 (2013) 58– 65 59
(Romanini et al., 2010). Moreover, 3 mg/kg was found to be at the peak of the
dose-response curve for the effects of sildenaﬁl on performance in rats tested in the
object recognition task (Prickaerts et al., 2005). Drug administration began soon
after the ﬁrst occlusion stage (VA) and continued for 9 days, with one dose per day.
Sildenaﬁl solution was freshly prepared before administration.
2.4. Behavioral testing
Learning and memory performance was measured in the aversive, eight-arm
radial maze (AvRM) model, which works on the basis of the rat’s natural behavior of
avoiding open and illuminated areas and its preference for darkened and enclosed
places (in this case, a shelter or goal box). A detailed description of the AvRM appara-
tus has been provided elsewhere (Romanini et al., 2010; Ferreira et al., 2011). After
habituation, acquisition training began according to a schedule of three trials per
session and one session per day for 15 days (5 days per week). In each trial, the rat
was  placed into the center of the arena, with all arms closed and the video camera
turned on. Thirty seconds later, the arms were opened simultaneously, and the ani-
mal  was allowed to explore the entire maze. When the rat entered halfway down
a  non-rewarded arm (i.e., an arm that contained a false goal box), the guillotine
doors of the remaining arms were lowered simultaneously. Upon the rat’s return
to  the central area, the newly visited arm was closed immediately, and the animal
was  again conﬁned in the arena for a further 10 s (delay). When the rat found and
entered halfway down the rewarded arm (i.e., the arm that contained the true goal
box), the guillotine door of that arm was lowered, forcing the animal to enter the
correct goal box where it was left for 1 min. If the rat did not ﬁnd the correct arm
within 4 min, then it was  placed into it and gently introduced into the shelter. If the
rat  inserted only its head into an incorrect opening and remained there for more
than  1 min, then it was repositioned to the center of the maze, and the trial was
restarted. If such atypical behavior persisted for more than four consecutive ses-
sions (days), then the animal was  excluded. Between trials, the rat was  moved from
the  maze (or goal box) to its individual home cage where it was left in a separate
room until the maze was cleaned of excrement and randomly rotated on its central
axis.  The goal box was randomly moved to any of the other seven arms, although its
spatial position in relation to the extra-maze cues remained unchanged across trials
and sessions and was the same for all of the rats. This procedure took approximately
90 s, after which the subsequent trial began. Learning and memory performance was
measured by three parameters: (i) the latency to ﬁnd the goal box, (ii) the number
of  reference memory errors, and (iii) the number of working memory errors. Within
a  given trial, a reference error was  counted when the rat visited an arm that con-
tained a false goal box for the ﬁrst time. However, if the rat returned to an arm
that had been visited previously during that trial, then a working memory error was
recorded. The animal was considered to have left an arm when it placed all four
paws on the central platform.
2.5. Histology
Under anesthesia (Thiopental, 50 mg/kg, i.v.), the animals were transcardially
perfused with 0.9% saline followed by Bouin’s ﬁxative (20 ml/min for 5 min). Follow-
ing decapitation, the head was immersed in crushed ice (1–2 ◦C) for at least 2 h to
avoid the appearance of so-called “dark” neurons. The brain was then removed and
immersed in the same ﬁxative for 2–3 h. The forebrain was sectioned into two parts
and conserved in the same ﬁxative for an additional 3–5 days, after which the parts
were embedded in parafﬁn. For each brain, 12 coronal sections (7 m thick, 70 m
apart) were cut at the medial level of the hippocampus (−3.60 to −4.30 mm)  and
processed for Nissl staining. Pyramidal cell loss was quantiﬁed bilaterally across the
CA1–CA4 subﬁelds of the hippocampus, in the retrosplenial (RS) cortex, and in the
parietal association (PtA) cortex. Neurodegeneration (or atrophy) was  also exam-
ined in the hippocampal dentate gyrus (DG). Because the high density of granular
cells in this region precludes the reliable determination of cell number, the thickness
of  the granular cell layer was measured in the suprapyramidal blade, infrapyramidal
blade, and crest of the DG. In both the hippocampus and cerebral cortex, the num-
ber  of pyramidal cells and thickness of the DG granular cell layer averaged from the
various measurements in each individual were transformed into a percentage. The
mean of the sham-operated group was considered 100%. Each individual value was
then normalized with respect to the mean of the sham. The identity of the groups
was  not revealed during histological assessment.
2.6. Statistical analysis
When learning and memory performance was analyzed across the ﬁve session
blocks, a normal distribution (D’Agostino and Pearson omnibus test), sphericity
(Mauchly’s test), and homocedasticity (Lavene’s test) were not consistently achieved
among the various groups, within the same group, or among the different param-
eters (i.e., latency, reference memory errors, and working memory errors). In this
case, nonparametric Friedman’s analysis of variance (ANOVA) was used to quantify
within-group differences, which tested the slope of the learning curve for each indi-
vidual group. If a global signiﬁcant value was found, then Dunn’s post hoc test was
applied to localize the session block when the reduction of the latency or number
of  errors (i.e., learning) was  signiﬁcant. Subsequently, the Kruskal–Wallis ANOVA
was used for between-group comparisons in each session block. However, when
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Fig. 2. Chronic cerebral hypoperfusion-induced learning deﬁcits in middle-aged rats and the effects of sildenaﬁl. (Upper panels) Temporal distribution of learning performance
expressed as latency (left), number of reference memory errors (middle), and number of working memory errors (right). (Lower panels) Total latency and total number of
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n  each testing block: #p < 0.05, ##p < 0.01, ###p < 0.001 vs.  sham.
earning performance was expressed as “total latency” and “total number of errors”
summed across 15 consecutive sessions), both a normal distribution and homo-
edasticity were achieved. In this case, a one-way ANOVA followed by Bonferroni’s
ost  hoc test was  used for between-group comparisons. The Kruskal–Wallis ANOVA
as  also used to quantify the results of the histological analysis. A proportion-like
-test was  used to quantify mortality data.
. Results
.1. Mortality rate
Overall, 23.4% of the rats died at some time point after the
ompletion of 4-VO/ICA when the animals were already conscious,
ikely reﬂecting the fatal effect of severe CCH. In the vehicle-treated
roup, 26% of the rats died (7/27, p < 0.001 vs. sham). The mortality
ate was lower in the sildenaﬁl-treated group (20%, 4/20, p < 0.05
s. sham) but not statistically different from the vehicle group. No
eath occurred after the sham operation.rformance, an effect that was  not changed by sildenaﬁl. The data are expressed as
rve slope): *p < 0.05, **p < 0.01, ***p < 0.001 vs. block 1. Between-group comparisons
3.2. Learning performance
Excluding the habituation period, learning performance assess-
ment began 93 days after 4-VO/ICA and 92 days after the last
dose of sildenaﬁl (see Fig. 1). Fig. 2 shows the disruptive effect
of 4-VO/ICA on acquisition performance in middle-aged rats
and the failure of sildenaﬁl to prevent this. The examination
of performance across training Sessions (Fig. 2, upper panels)
revealed that the parameters “latency” and “number of reference
errors” decreased signiﬁcantly in all three groups (S = 10.34–39.70,
p < 0.0001–0.05). As training proceeded, the “number of work-
ing errors” also decreased in the sham group (S = 17.42, p < 0.01)
and vehicle group (S = 12.82, p < 0.05) but not in the sildenaﬁl-
treated group. Dunn’s post hoc test showed that the rate of learning
was similar between the sham and vehicle groups, with values
of “latency” and “number of reference errors” that were sig-
niﬁcantly lower for blocks 3, 4, and 5 compared with block 1
(p < 0.001–0.05). A less robust learning rate was observed in the
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Fig. 3. Chronic cerebral hypoperfusion-induced neurodegeneration over the CA1–CA4 subﬁelds of the hippocampus and the effect of sildenaﬁl. In each rat, a mean value of
hippocampal cells was taken from six measurements (3 sections ×2 hemispheres). Each dot represents an individual, averaged cell count, which was  normalized to the mean
of  the sham-operated group (100%). The bars denote the mean ± SEM of the group. (Left, upper panel) Low-magniﬁcation (50×, scale bar = 500 m), Nissl-stained coronal
brain  section at the intermediate level of the hippocampus obtained from a sham-operated rat that shows the CA1–CA4 subﬁelds. (Right panel) High-magniﬁcation (400×,
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rrows  and arrowheads indicate normal-looking and degenerating neurons, respec
ats  were lost during histological preparation. Sham, n = 11; vehicle, n = 20; sildenaﬁ
ildenaﬁl-treated group (latency, block 5 vs. block 1, p < 0.05). These
ata indicate that hypoperfused rats also learned the task during
raining. However, between-group comparisons in each training
lock revealed that the vehicle-treated group spent more time to
nd the goal box (K–W = 12.98–16.61, p < 0.01–0.05) and commit-
ed more reference memory errors (K–W = 12.04–12.42, p < 0.05)
han the sham surgery group, reﬂecting 4-VO/ICA-induced learn-
ng impairment. This learning deﬁciency was  not prevented by
ildenaﬁl (p < 0.001–0.05 vs.  sham; p > 0.05 vs.  vehicle). The failure
f sildenaﬁl to reduce 4-VO/ICA-induced learning deﬁcits became
ore evident when the cumulative latency and number of refer-
nce errors were analyzed (F2,47 = 7.64–10.83, p < 0.01–0.05 vehicle
s. sham, p < 0.001 sildenaﬁl vs.  sham; p > 0.05 sildenaﬁl vs.  vehicle;
ig. 2, lower panels).
.3. Histological analysis
Compared with sham operation, permanent 4-VO/ICA caused
oderate-to-severe neurodegeneration over the entire CA1–CA4
yramidal stratum (56.2% cell loss, K–W = 30.61, p < 0.001; Fig. 3),
G (19.2% cell loss, K–W = 19.61, p < 0.001; Fig. 4), and cerebral cor-
ex (47.4% cell loss in the RS cortex, K–W = 30.37, p < 0.001; 38.2%
ell loss in the PtA cortex, K–W = 33.62, p < 0.001; Fig. 5). Sildenaﬁl
reatment signiﬁcantly reduced neurodegeneration in all of these
rain regions (30.5% cell loss in the CA1–CA4, 7.8% cell loss in the
G, 11.8% cell loss in the RS cortex, 6.5% cell loss in the PtA cortex;
 < 0.001–0.05 sildenaﬁl vs. vehicle).
. Discussion
In this study, sildenaﬁl treatment reduced neurodegeneration in
oth the CA1–CA4 stratum of the hippocampus and cerebral cortex
n middle-aged rats subjected to CCH. Granular cells in the DG were
lso preserved by sildenaﬁl, reﬂected by the maintenance of the
hickness of the cell layer. In the RS and PtA cortices, the numberf rats assigned to sham operation, 4-VO/ICA + vehicle, or 4-VO/ICA + sildenaﬁl. The
. ***p < 0.0001 vs. sham, ###p < 0.0001 vs. vehicle. The brains of two sham-operated
16.
of normal-looking, Nissl-stained pyramidal cells in the 4-VO/ICA
group treated with sildenaﬁl approached the number in the sham-
operated animals, indicating robust histological protection. Despite
this, however, sildenaﬁl failed to promote learning recovery, clearly
indicating a dissociation between neurohistological and functional
protection.
Compared to our previous ﬁndings (Romanini et al., 2010), the
present study demonstrated that the neuroprotective effect of sil-
denaﬁl goes beyond the pyramidal stratum of the hippocampus,
extending to the granular cell layer of the DG and cerebral cortex.
This is important, since it suggests that other brain regions that
are possibly damaged by CCH, mainly the striatum and thalamus,
might also have been protected by sildenaﬁl. Another important
aspect of the present histological data refers to the long survival
time (i.e., 107 days) elapsed between the end of treatment and the
histological analysis. Compared to the 27-day survival time used in
Romanini’s study, the present ﬁndings suggest more convincingly
that sildenaﬁl-mediated histological neuroprotection after CCH is a
consistent and enduring effect. This is relevant because the degree
of neuroprotection afforded by other drugs, such as the -amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist
NBQX, N-channel calcium blocker SNX, and noncompetitive N-
methyl-D-aspartate antagonist MK801, or non-pharmacologically
(e.g., hypothermia and preconditioning) was shown to decline
when the postischemic survival time of the analysis was  extended
from the ﬁrst 7 days to 30 days overall (Corbett and Crooks, 1997).
Moreover, the present study extended to middle-aged rats the anal-
ysis on the effects of sildenaﬁl after CCH. This may render the data
more relevant from a clinical point of view, since aging-related
morbidities such as hypertension, atherosclerosis and chronic heart
disease are major risk factors for CCH (de la Torre, 2009).Our study does not provide mechanistic insights into how sil-
denaﬁl afforded long-lasting histological protection. In this regard
and considering the primary action of sildenaﬁl on vascular smooth
muscles, one may  speculate whether vascular or nonvascular
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Fig. 4. Chronic cerebral hypoperfusion-induced atrophy in the DG granular cell layer and the effect of sildenaﬁl. In each rat, a mean value of granular cell layer thickness
was  taken from 18 measurements (3 locations × 3 sections × 2 hemispheres). Each dot represents an individual, averaged thickness measurement, which was normalized
to  the mean of the respective sham-operated group (100%). The bars denote the mean ± SEM of the group. (Left, upper panel) Low-magniﬁcation (50×, scale bar = 500 m)
image  obtained from a sham-operated rat that shows the locations (rectangles) where the thickness of the DG granular cell layer was measured at the suprapyramidal blade
(DGs),  infrapyramidal blade (DGi), and crest (DGc). (Right panels) High-magniﬁcation (400×, scale bar = 50 m),  representative photomicrographs of the DG granular cell layer
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echanisms play a role. Whether the primary action of sildenaﬁl
i.e., vasorelaxation in the vascular bed of the corpus cavernosum
nd lungs) can translate into increased global cerebral blood
ow (CBF) is unclear (Ghofrani et al., 2006). Unfortunately, we
ere not instrumentally equipped to investigate whether silden-
ﬁl improves CBF after permanent 3-stage 4-VO/ICA, which may
ave helped answer this question. In rats, cerebral PDE5 pro-
ein was predominantly found in vascular smooth muscles of
eningeal arteries and also in some deeper parenchymal microves-
els (Menniti et al., 2009). The PDE5A enzyme is also present and
ctive in the basilar artery in guinea pigs (Kruuse et al., 2003).
oreover, sildenaﬁl was found to increase the level of cGMP in
he cerebral cortex (Zhang et al., 2002, 2005) and hippocampus
Prickaerts et al., 2002). These ﬁndings suggest that PDE5 may  also
xert a vascular effect in the brain. However, whether sildenaﬁl
ncreases global CBF is controversial. To our knowledge, only one
esearch group has evaluated the effect of sildenaﬁl on CBF under
onditions of cerebral ischemia. Administered 24 h after stroke and
aily for 6 or 7 days, sildenaﬁl slightly but signiﬁcantly increased
egional CBF in both young rats (Li et al., 2007) and aged rats
Ding et al., 2011). Such an effect persisted for up to 6 weeks post-
troke and coincided with improved functional recovery in young
ats (Li et al., 2007). In these previous studies, however, CBF was
stimated in the boundary region of the infarcted tissue where
ncreased angiogenesis and axonal remodeling was  also observed.
his may  have accounted for the sildenaﬁl-induced improvement
f regional CBF (Ding et al., 2011). In a similar study, treatment
ith the potent PDE5A inhibitor PF-5 began 24 h after stroke and
ontinued daily for 7 days, resulting in nearly complete recovery
f sensorimotor function measured 3 months later (Menniti et al.,
009). Although CBF was not measured in that study, the authors
peculated that the acute effects of sildenaﬁl on cerebral perfusion
ay  have accounted for the rapid onset of sensorimotor function
ecovery. If so, then we may  also suggest that a global and acuteildenaﬁl. Dotted vertical lines outline the qualitative thickness of the DG granular
n = 16.
effect of sildenaﬁl on brain perfusion contributed to the reversal of
the high mortality rate observed after permanent 2-stage 4VO/ICA
(Romanini et al., 2010). These ﬁndings or interpretations derived
from animal experimentation suggest that sildenaﬁl may improve
CBF globally. This is not supported, however, by observations in
humans, in which sildenaﬁl treatment did not change either blood
ﬂow velocity (Arnavaz et al., 2003) or the diameter of the middle
cerebral artery, indicating that sildenaﬁl did not dilate cerebral or
extracerebral arteries (Kruuse et al., 2003). Remaining uncertain,
therefore, is whether sildenaﬁl-mediated neuroprotection could be
associated with improved global CBF.
Alternatively, sildenaﬁl may  afford histological protection
through a preconditioning-like action. Sildenaﬁl-induced precon-
ditioning has been consistently observed in the rabbit and mouse
myocardium subjected to ischemia, an effect that appears to be pri-
marily mediated by NO derived from inducible nitric oxide synthase
(iNOS; Kukreja et al., 2005). The cardioprotective effect of sildenaﬁl
was abolished in cardiomyocytes derived from iNOS gene knockout
mice, clearly demonstrating the critical role played by NO-related
pathways in mediating the beneﬁcial effect of sildenaﬁl on the
myocardium (Das et al., 2005). The activation of mitochondrial
adenosine triphosphate-sensitive K+ channels and mitochondrial
Ca2+-activated K+ channels has also been found to represent majors
signaling mechanisms by which sildenaﬁl-induced preconditioning
results in cardioprotection (Wang et al., 2008). In association with
or apart from preconditioning, sildenaﬁl also reduced apoptosis in
the ischemic myocardium (Das et al., 2005). Interestingly, silden-
aﬁl given for 8 days also reduced apoptosis in the mouse cerebral
cortex after hypoxia (Caretti et al., 2008). Additionally, sildenaﬁl
stimulated the expression of vascular endothelial growth factor
(Caretti et al., 2008), an effect consistent with the observation that
sildenaﬁl administered after stroke promoted angiogenesis in the
periinfarct region (Li et al., 2007; Ding et al., 2011). Considering the
presence and activity of both PDE5 and NO/cGMP in the brain and
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Fig. 5. Chronic cerebral hypoperfusion-induced neurodegeneration in the retrosplenial cortex (RS) or parietal association (PtA) cortex. Digital microscopic areas (rectangles,
361  m × 270 m,  40× objective) were captured from the RS or PtA cortex. In each animal, a mean value for the RS cortex was obtained from six measurements (1 area × 3
sections  × 2 hemispheres). In the PtA cortex, 12 measurements were made for each rat (2 areas × 3 sections × 2 hemispheres). Each dot represents an individual, the value
of  which was normalized to the mean of the sham-operated group (100%). The bars denote the mean ± SEM of the groups. (Left, upper panel) Low-magniﬁcation (50×,
scale  bar = 500 m),  Nissl-stained coronal brain section that shows the location of the digital areas captured from the RS and PtA cortices. (Right panel) High-magniﬁcation
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nvolvement of NO-related pathways in the mediation of the pro-
ective effect of sildenaﬁl in the myocardium (Das et al., 2005),
e may  speculate that sildenaﬁl-mediated preconditioning via
ctivation of the NO/cGMP pathway may  have accounted for its
europrotective effect after CCH. If so, then the question arises how
uch an action preserved neurons for at least 107 days of brain
ypoperfusion, despite the discontinuation of sildenaﬁl treatment
oon after the completion of permanent 4-VO/ICA.
Finally, the present study demonstrated that sildenaﬁl-
ediated hippocampal and cortical neuroprotection did not
ranslate into recovery from learning deﬁcit after CCH. This infor-
ation was lacking in the study by Romanini and cols. (2008),
s young rats were not impacted cognitively by permanent 4-
O/ICA. This was conﬁrmed later, when 3-stage 4-VO/ICA (i.e.,
V → ICA → ICA) with an ISI (→)  as shorter as 2 days also failed
o cause learning deﬁcit in young rats, but disrupted it in older rats
Ferreira et al., 2011). The impact of permanent, 3-stage 4-VO/ICA
n memory performance of middle-aged rats was  conﬁrmed subse-
uently (Pereira et al., 2012). Therefore, the use of middle-aged rats
r older ones seems to be a requisite if both neurohistological and
ognitive outcome are to be measured after permanent 4-VO/ICA.
Because long-lasting neuroprotection was provided by sildena-
l in both hippocampus and cerebral cortex, the lack of behavioral
ecovery is intriguing. The cerebral cortex and its reciprocal con-
ections with the hippocampus appear to be crucial for processing
omplex learning and memory tasks, including the radial maze task
Eichenbaum, 2000; Wall and Messier, 2001; Dalley et al., 2004;
ee and Kesner, 2003). Also, damage restricted to the RS cortex
as been consistently shown to compromise the ability of rats
o solve the radial maze task (Keene and Bucci, 2009). Therefore,
isruption of hippocampal/cortical circuitry may at least partially
nderlie the effect of chronic 4-VO/ICA on learning and mem-
ry performance in middle-aged rats (Ferreira et al., 2011; Pereira
t al., 2012). Ample evidence also indicates that sildenaﬁl and otherortex of rats assigned to sham operation, 4-VO/ICA + vehicle, or VO/ICA + sildenaﬁl.
vely. ***p < 0.0001 vs. sham; ###p < 0.0001 vs. vehicle. Sham, n = 11; vehicle, n = 20;
selective PDE5 inhibitors administered soon before or after training
improve learning and memory performance in different behavioral
tasks (Reneerkens et al., 2009). Although a direct inﬂuence of PDE5
inhibitors on overall CBF cannot be discarded, the behavioral effects
described in response to these agents have been attributed to
neuronal alterations (Ghofrani et al., 2006). Based on these assump-
tions, a key aspect of the present study is that a period greater
than 3 months elapsed between the end of sildenaﬁl treatment and
the beginning of behavioral testing. Any acute effect of sildenaﬁl
exerted during the administration period on neuronal or vascu-
lar domains unlikely inﬂuenced learning performance measured
3 months later. More likely is that sildenaﬁl-mediated neuropro-
tection persists as a major, if not unique, effect that theoretically
could ensure recovery from learning deﬁcits. This was not the case,
however. Neurohistological protection was not accompanied by
functional improvement, at least under the present experimen-
tal conditions. Similar phenomena have been found by others.
For example, robust neuroprotection was observed in the CA1
subﬁeld of the hippocampus after ischemic preconditioning in ger-
bils. Such a degree of neuroprotection was not only devoid of
recovery of locomotor behavior in the open ﬁeld but also asso-
ciated with a decrease in locomotor behavior by approximately
30% when the postischemic survival time was extended from
10 to 30 days (Corbett and Crooks, 1997). Robust CA1 neuro-
protection without behavioral recovery has also been observed
after postischemic treatment with hypothermia (Colbourne and
Corbett, 1995). Altogether, these data and the present study indi-
cate that histological preservation does not necessarily translate
into long-term functional recovery after brain damage (Green et al.,
1992; Colbourne and Corbett, 1995; Corbett and Nurse, 1998). One
possible reason for such a dissociation between histological and
functional preservation is that the neurons that appeared to be nor-
mal  in the morphometric analysis no longer functioned normally
or were insufﬁcient to ensure behavioral recovery. For example,
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henobarbital provided complete protection against ischemia-
nduced hippocampal CA1 cell death, but the response of those cells
o KCl-stimulated acetylcholine release remained impaired. Addi-
ionally, acetylcholinesterase immunoreactivity was almost absent
n CA1 neurons that exhibited normal Nissl staining (Ishimaru
t al., 1995). Furthermore, ischemic preconditioning also pre-
erved CA1 pyramidal cells from death, demonstrated by Nissl
taining, but they were found to be electrophysiologically dys-
unctional because their dendritic extracellular ﬁeld potentials
ere signiﬁcantly smaller than those recorded from non-ischemic
nimals (Corbett and Nurse, 1998). Similar subcellular distur-
ances may  have occurred in the present case, determining the
bserved learning impairment despite marked neuronal preser-
ation by sildenaﬁl. This interpretation agrees with the general
onsensus that “dysfunction of complex behaviors and recovery
ay  reﬂect alterations at the subcellular, synaptic or electrophys-
ological level, or even of widespread morphological changes that
annot be quantiﬁed by a simple cell count in a restricted region
f a given structure” (Aronowski et al., 1996). Accordingly and
espite the importance of preserving as many neurons as possi-
le after an hypoxic/ischemic event (Corbett and Nurse, 1998), true
europrotection goes beyond simple cells preservation to include
eurochemical and electrophysiological normalization followed by
ong-term behavioral recovery.
In conclusion, the present study demonstrated that sildenaﬁl
fforded sustained histological neuroprotection after chronic cere-
ral hypoperfusion in middle-aged rats, an effect that was not
ccompanied by the recovery of learning performance assessed
ong after sildenaﬁl treatment. Our interpretation is that the neu-
ons rescued by sildenaﬁl in the hippocampus, RS and PtA cortices,
nd perhaps other brain structures not examined here were no
onger functional or insufﬁcient to ensure behavioral recovery.
he present ﬁndings do not discard, however, the possibility that
ildenaﬁl effectively preserves cognitive function after CCH. For
xample, the PDE3 inhibitor cilostazol administered continuously
uring the entire duration of behavioral testing in the water maze
ask preserved learning performance after CCH (Watanabe et al.,
006). Therefore, future studies will need to examine whether other
dministration or dosing regimens and other behavioral protocols
ould reveal the efﬁcacy of sildenaﬁl in promoting functional recov-
ry after CCH. Furthermore, a comparative study of sildenaﬁl and
ilostazol should be pursued, the results of which may  shed light
n the role of different PDE isoforms in the mediation of the ther-
peutic potential of PDE inhibitors in the setting of CCH.
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